Stocks Health care PMI
NYSE · Health carePicard Medical, Inc. (PMI)
Picard Medical, Inc. brought in $6.3M of revenue over the twelve months to June 30, 2026. It posted a net loss of $28M. At June 30, 2026 it held $38K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.
Key facts about Picard Medical, Inc.
- Net worth
- Picard Medical, Inc. has a market value (market cap) of $16M at the latest share price, and shareholders' equity of $1.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $4.9M (+12.5% year on year), with a net loss of $27M. Over the 12 months to June 30, 2026: revenue $6.3M, net loss $28M.
- Cash flow
- In fiscal 2025 operations used $15.7M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 19, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
What Picard Medical, Inc. does
Picard Medical, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker PMI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $4.9M | -$27M | -$0.75 | n/a |
| 2025 | $4.4M | -$21.1M | -$2.99 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where PMI ranks in Health care
Latest SEC filings
What Picard Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 6, 2026New debt 8-K
- August 20, 2026
- August 19, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 39% to $3M versus the same quarter last year; diluted EPS -$3.05 versus -$42.39.
- August 17, 2026Late quarterly report notice NT 10-Q
- August 7, 2026Passive stake changed SCHEDULE 13G/A
- July 27, 2026
- July 22, 2026
- July 21, 2026
- July 16, 2026Additional proxy material DEFA14A
- July 13, 2026Other event 8-K/A
Insider trades
What the people running Picard Medical, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns PMI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Hudson Bay Capital Management LP13G, passive with 1 related filers | 9.99% | August 7, 2026 |
Largest institutional holders
Insiders
Questions about PMI
What does Picard Medical, Inc. do?
Picard Medical, Inc. is a company in the Health care sector, listed on NYSE as PMI. Its shares trade on NYSE under the ticker PMI.
What is Picard Medical, Inc.'s net worth?
Picard Medical, Inc. has a market value (market cap) of $16M at the latest share price, and shareholders' equity of $1.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Picard Medical, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $28M on revenue of $6.3M.
How much revenue does Picard Medical, Inc. make?
Over the twelve months to June 30, 2026 Picard Medical, Inc. reported revenue of $6.3M.
When did Picard Medical, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the new debt from October 6, 2026.
Similar companies
Compare PMI with
Follow PMI
Get an email when Picard Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Picard Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.